Lilly gearing up for 'substantial expansion' of diabetes med manufacturing by 2025

Acelyrin sets hopes high for arthritis drug with $300M fundraise

Novartis forecasts improving generic drug business as it weighs unit’s future

Merck study results signal blood cancer potential for new type of immunotherapy

Bristol Myers’ autoimmune drug shows potential in lupus.

Pfizer says 3 doses of its COVID-19 vaccine works in youngest children

Pfizer, Lilly bolster cases for experimental ulcerative colitis drugs

Merck counting on heart drugs to boost business next decade

Adagio plans comeback for COVID drug, but is it too late?